Abstract
SSX, a family of genes clustered on the X chromosome, has been identified as a cancer–testis antigen and also forms a part of the SYT–SSX fusion gene found in synovial sarcoma, implying that it has an important role in tumorigenesis. However, knowledge of the molecular regulation of SSX is still limited. In this study, we demonstrate that SSX or its SYT fusion protein is distributed as nuclear speckles, in which it is co-localized with B cell-specific Moloney murine leukemia virus insertion site 1 (Bmi1), which is a core factor of polycomb repressor complex 1. The C-terminal residues of SSX are indispensable for the nuclear speckle distribution, while the N-terminal domain is necessary for the recruitment of Bmi1, indicating that intact SSX must be needed for interaction with Bmi1 both spatially and functionally. In addition, the N-terminus of SSX also proved to contain an intrinsic nucleolar localization signal, which mediates the nucleolar translocation of SSX in particular kinds of cell stress such as the oxidation of hydrogen peroxide or heat shock. This stress-induced translocation is reversible and accompanied by HSP 70 or p14ARF traffic, suggesting that SSX is a stress response gene. It is of note that nucleolar translocation of SSX can result in disassociation of SSX from Bmi1, with consequent down-regulation of Bmi1 activity. These novel findings regarding distinct domains of SSX and its interaction with Bmi1 may shed light on the mechanism by which synovial sarcoma develops and on the up-regulation of SSX in cancer cells.
Similar content being viewed by others
References
Güre AO, Wei IJ, Old LJ, Chen YT (2002) The SSX gene family: characterization of 9 complete genes. Int J Cancer 101:448–453
Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT (2002) Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 188:22–32
Smith HA, McNeel DG (2010) The SSX family of cancer-testis antigens as target proteins for tumor therapy. Clin Dev Immunol. doi:10.1155/2010/150591
Crew A, Clark J, Fisher C, Gill S, Grimer R, Chand A, Shipley J, Gusterson B, Cooper C (1995) Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J 14:2333–2340
de Leeuw B, Balemans M, Olde Weghuis D, Geurts van Kessel A (1995) Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2, in t(X;18)(p11.2;q11.2)-positive synovial sarcomas. Hum Mol Genet 4:1097–1099
Agus V, Tamborini E, Mezzelani A, Pierotti MA, Pilotti S (2001) Re: A novel fusion gene, SYT–SSX4, in Synovial Sarcoma. J Natl Cancer Inst 93:1347–1349
Lim FL, Soulez M, Koczan D, Thiesen HJ, Knight JC (1998) A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas. Oncogene 17:2013–2018
Brett D, Whitehouse S, Antonson P, Shipley J, Cooper C, Goodwin G (1997) The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies. Hum Mol Genet 6:1559–1564
Soulez M, Saurin AJ, Freemont PS, Knight JC (1999) SSX and the synovial-sarcoma-specific chimaeric protein SYT–SSX co-localize with the human Polycomb group complex. Oncogene 18:2739–2746
dos Santos NR, de Bruijn DRH, Kater-Baats E, Otte AP, van Kessel AG (2000) Delineation of the protein domains responsible for SYT, SSX, and SYT–SSX nuclear localization. Exp Cell Res 256:192–202
Park IK, Morrison SJ, Clarke MF (2004) Bmi1, stem cells, and senescence regulation. J Clin Invest 113:175–179
Satijn DPE, Otte AP (1999) Polycomb group protein complexes: do different complexes regulate distinct target genes. Biochim Biophys Acta 1447:1–16
Shao Z, Raible F, Mollaaghababa R, Guyon JR, Wu C, Bender W, Kingston RE (1999) Stabilization of chromatin structure by PRC1, a Polycomb complex. Cell 98:37–46
Meng S, Luo M, Sun H, Yu X, Shen M, Zhang Q, Zhou R, Ju X, Tao W, Liu D (2010) Identification and characterization of Bmi-1-responding element within the human p16 promoter. J Biol Chem 285:33219–33229
Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K (2006) Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Gene Dev 20:1123–1136
Guo WJ, Datta S, Band V, Dimri GP (2007) Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi1 and c-Myc oncoproteins. Mol Biol Cell 18:536–546
Yang J, Chai L, Liu F, Fink LM, Lin P, Silberstein LE, Amin HM, Ward DC, Ma Y (2007) Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells. Proc Natl Acad Sci USA 104:10494–10499
Li SKM, Smith DK, Leung WY, Cheung A, Lam EWF, Dimri GP, Yao KM (2008) FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi1 expression. J Biol Chem 283:16545–16553
Lessard J, Sauvageau G (2003) Bmi1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423:255–260
Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ (2003) Bmi1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425:962–967
Raaphorst FM (2003) Self-renewal of hematopoietic and leukemic stem cells: a central role for the Polycomb-group gene Bmi1. Trends Immunol 24:522–524
Liu S, Dontu G, Mantle ID, Patel S, Ahn N, Jackson KW, Suri P, Wicha MS (2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66:6063–6071
Barco R, Garcia CB, Eid JE (2009) The synovial sarcoma-associated SYT–SSX2 oncogene antagonizes the polycomb complex protein Bmi1. PLoS ONE 4:e5060
Groner AC, Meylan S, Ciuffi A, Zangger N, Ambrosini G, Dénervaud N, Bucher P, Trono D (2010) KRAB–zinc finger proteins and KAP1 can mediate long-range transcriptional repression through heterochromatin spreading. PLoS Genet 6:e1000869
Stoop H, van Gurp R, de Krijger R, van Kessel AG, Köberle B, Oosterhuis W, Looijenga L (2001) Reactivity of germ cell maturation stage-specific markers in spermatocytic seminoma: diagnostic and etiological implications. Lab Invest 8:919–928
Gallagher SJ, Kefford RF, Rizos H (2006) The ARF tumour suppressor. Int J Biochem Cell Biol 38:1637–1641
Zeng Y, He Y, Yang F, Mooney SM, Getzenberg RH, Orban J, Kulkarni P (2011) The cancer/testis antigen prostate-associated gene 4 (PAGE4) is a highly intrinsically disordered protein. J Biol Chem 286:13985–13994
Marcar L, MacLaine NJ, Hupp TR, Meek DW (2010) Mage-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatin. Cancer Res 70:10362–10370
Gure AO, Türeci Ö, Sahin U, Tsang S, Scanlan MJ, Jäger E, Knuth A, Pfreundschuh M, Old LJ, Chen YT (1997) SSX: a multigene family with several members transcribed in normal testis and human cancer. Int J Cancer 72:965–971
Türeci Ö, Chen YT, Sahin U, Güre AO, Zwick C, Villena C, Tsang S, Seitz G, Old LJ, Pfreundschuh M (1998) Expression of SSX genes in human tumors. Int J Cancer 77:19–23
dos Santos NR, Torensma R, de Vries TJ, Schreurs MWJ, de Bruijn DRH, Kater-Baats E, Ruiter DJ, Adema GJ, van Muijen GNP, van Kessel AG (2000) Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines. Cancer Res 60:1654–1662
Acknowledgments
This project (No. 3077830, No. 30570691, No. 81171907) supported by National Natural Science Foundation of China, and the Research Fund for the Doctoral Program of Higher Education (200800010060).
Author information
Authors and Affiliations
Corresponding author
Additional information
Jiaochen Wang and Huali Wang contributed equally to this work.
Rights and permissions
About this article
Cite this article
Wang, J., Wang, H., Hou, W. et al. Subnuclear distribution of SSX regulates its function. Mol Cell Biochem 381, 17–29 (2013). https://doi.org/10.1007/s11010-013-1684-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-013-1684-9